JP2013513387A - 循環器疾患の診断と分類のためのバイオマーカーアッセイ - Google Patents

循環器疾患の診断と分類のためのバイオマーカーアッセイ Download PDF

Info

Publication number
JP2013513387A
JP2013513387A JP2012543298A JP2012543298A JP2013513387A JP 2013513387 A JP2013513387 A JP 2013513387A JP 2012543298 A JP2012543298 A JP 2012543298A JP 2012543298 A JP2012543298 A JP 2012543298A JP 2013513387 A JP2013513387 A JP 2013513387A
Authority
JP
Japan
Prior art keywords
classification
mir
data
analysis
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012543298A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013513387A5 (enExample
Inventor
ハリントン、ダグ
ハイトポウロス、エヴァンゲロス
フェルプス、ブルース
Original Assignee
アヴィール インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アヴィール インコーポレイテッド filed Critical アヴィール インコーポレイテッド
Publication of JP2013513387A publication Critical patent/JP2013513387A/ja
Publication of JP2013513387A5 publication Critical patent/JP2013513387A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/30—Unsupervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Data Mining & Analysis (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Databases & Information Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Epidemiology (AREA)
  • Theoretical Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Artificial Intelligence (AREA)
  • Primary Health Care (AREA)
  • Bioethics (AREA)
  • Software Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Evolutionary Computation (AREA)
  • Cell Biology (AREA)
JP2012543298A 2009-12-09 2010-12-09 循環器疾患の診断と分類のためのバイオマーカーアッセイ Pending JP2013513387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28512109P 2009-12-09 2009-12-09
US61/285,121 2009-12-09
PCT/US2010/059781 WO2011072177A2 (en) 2009-12-09 2010-12-09 Biomarker assay for diagnosis and classification of cardiovascular disease

Publications (2)

Publication Number Publication Date
JP2013513387A true JP2013513387A (ja) 2013-04-22
JP2013513387A5 JP2013513387A5 (enExample) 2014-02-13

Family

ID=43587661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543298A Pending JP2013513387A (ja) 2009-12-09 2010-12-09 循環器疾患の診断と分類のためのバイオマーカーアッセイ

Country Status (7)

Country Link
US (2) US20110144914A1 (enExample)
EP (1) EP2510116A2 (enExample)
JP (1) JP2013513387A (enExample)
CN (1) CN102762743A (enExample)
AU (1) AU2010328019A1 (enExample)
CA (1) CA2783536A1 (enExample)
WO (1) WO2011072177A2 (enExample)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013528055A (ja) * 2010-06-07 2013-07-08 キングス カレッジ ロンドン 検出方法
JP2016114606A (ja) * 2014-12-15 2016-06-23 学校法人 久留米大学 腎性貧血のバイオマーカーとしての赤血球ａｄｍａの使用
JP2017530356A (ja) * 2014-09-26 2017-10-12 ソマロジック, インコーポレイテッドSomaLogic, Inc. 心血管系のリスクイベントの予測及びその使用
KR101903526B1 (ko) * 2015-08-19 2018-10-05 한국전자통신연구원 바이오 물질의 농도를 기반으로 하는 질환 예측 장치 및 그것의 질환 예측 방법
JP2019507354A (ja) * 2016-02-01 2019-03-14 プレベンシオ， インコーポレイテッド 心臓血管疾患及び事象のための診断及び予後方法
JP2019511242A (ja) * 2016-01-22 2019-04-25 ユニヴェルシテ ドュ モンペリエＵｎｉｖｅｒｓｉｔｅ Ｄｅ Ｍｏｎｔｐｅｌｌｉｅｒ 生物学的サンプルを分類する方法
JP2019513993A (ja) * 2016-03-31 2019-05-30 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 急性冠症候群のリスクを推定するための決定木ベースのシステム及び方法
JP2022505676A (ja) * 2018-10-23 2022-01-14 ブラックソーン セラピューティクス インコーポレイテッド 患者のスクリーニング、診断、及び層別化のためのシステム及び方法
JP2022550598A (ja) * 2019-10-02 2022-12-02 エンドポイント ヘルス インコーポレイテッド 宿主反応調節不全の治療を誘導するためのバイオマーカーパネル
JP2023502197A (ja) * 2019-11-04 2023-01-23 オックスフォード ユニバーシティ イノベーション リミティド 除草剤および植物成長調節剤の特定および特性決定

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10359425B2 (en) 2008-09-09 2019-07-23 Somalogic, Inc. Lung cancer biomarkers and uses thereof
WO2011056186A1 (en) * 2009-10-26 2011-05-12 Albert Einstein College Of Medicine Of Yeshiva University Microrna affinity assay and uses thereof
EP2865765B1 (en) * 2010-04-20 2016-08-17 Hummingbird Diagnostics GmbH Complex miRNA sets as novel biomarkers for an acute coronary syndrome
MX355020B (es) 2010-07-09 2018-04-02 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
JP5931874B2 (ja) 2010-08-13 2016-06-08 ソマロジック・インコーポレーテッド 膵癌バイオマーカーおよびその使用
TW201231671A (en) * 2011-01-28 2012-08-01 Univ Kaohsiung Medical Method and kit for in vitro diagnosis of atherosclerosis
EP2714934B1 (en) * 2011-05-24 2018-09-19 Rosetta Genomics Ltd Methods and compositions for determining heart failure or a risk of heart failure
US9708643B2 (en) * 2011-06-17 2017-07-18 Affymetrix, Inc. Circulating miRNA biomaker signatures
CN103988076A (zh) 2011-08-12 2014-08-13 阿尔弗雷德医疗集团 包括测量巨噬细胞移动抑制因子（mif）的血浆浓度的诊断、预后或治疗急性冠状动脉综合征（acs）的方法
SG10201607331WA (en) * 2011-09-30 2016-11-29 Somalogic Inc Cardiovascular risk event prediction and uses thereof
WO2013060894A1 (en) * 2011-10-27 2013-05-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment and diagnosis of atherosclerosis
CN103103189B (zh) * 2011-11-14 2015-06-03 中国科学院上海生命科学研究院 过表达单一MicroRNA成熟体序列的新方法
CN103160507B (zh) * 2011-12-19 2017-05-24 上海交通大学医学院附属新华医院 检测肝硬化的miRNA血清标志物及其应用
ITRM20110685A1 (it) 2011-12-23 2013-06-24 Internat Ct For Genetic En Gineering And Microrna per la rigenerazione cardiaca attraverso l induzione della proliferazione dei miociti cardiaci
ES2886979T3 (es) 2012-02-09 2021-12-21 Memed Diagnostics Ltd Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos
US10417575B2 (en) * 2012-12-14 2019-09-17 Microsoft Technology Licensing, Llc Resource allocation for machine learning
DE102012101557A1 (de) * 2012-02-27 2013-08-29 Charité Universitätsmedizin Berlin Verwendung von microRNAs oder Genen als Marker zur Identifizierung, Diagnose und Therapie einzelner nicht-ischämischer Kardiomyopathien oder Speichererkrankungen des Herzens
CN102708384B (zh) * 2012-06-04 2014-01-29 西南交通大学 一种基于随机蕨的自举弱学习方法及其分类器
US9002769B2 (en) * 2012-07-03 2015-04-07 Siemens Aktiengesellschaft Method and system for supporting a clinical diagnosis
US9336302B1 (en) 2012-07-20 2016-05-10 Zuci Realty Llc Insight and algorithmic clustering for automated synthesis
CN102839172B (zh) * 2012-08-24 2013-09-25 中国医科大学附属第一医院 HIV感染疾病进展分子标志物miR-503
US20140087964A1 (en) * 2012-09-24 2014-03-27 University Of Virginia Patent Foundation Compositions and methods for detecting aberrant regulation, expression, and levels of hgh
US9996889B2 (en) * 2012-10-01 2018-06-12 International Business Machines Corporation Identifying group and individual-level risk factors via risk-driven patient stratification
CN102980920A (zh) * 2012-11-14 2013-03-20 华东师范大学 同时检测miRNAs与蛋白标记物的硅纳米线芯片及其检测方法和应用
CN103233007A (zh) * 2013-02-05 2013-08-07 中国科学院广州生物医药与健康研究院 hsa-miR-545miRNA及其应用
CA2903781C (en) * 2013-03-04 2023-08-08 Board Of Regents Of The University Of Texas System System and method for determining triage categories
CA2907025A1 (en) * 2013-03-15 2014-09-18 The Hospital For Sick Children Diagnostic and therapeutic methods relating to microrna-144
CN103205505B (zh) * 2013-05-03 2014-11-05 周玲 一种诊断妊娠糖尿病的microRNA分子标志物及其检测试剂盒
KR20150007468A (ko) * 2013-07-11 2015-01-21 (의료)길의료재단 임상의사결정 지원방법 및 그 장치
US9953417B2 (en) * 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
CN104357554B (zh) * 2013-11-26 2016-08-24 上海中医药大学附属岳阳中西医结合医院 微小核苷酸hsa-miR939在高血压诊断中的应用
CN103642914B (zh) * 2013-11-29 2015-02-25 中国人民解放军第四军医大学 与恶性黑素瘤相关的血浆/血清循环microRNA标志物及其应用
US10817791B1 (en) * 2013-12-31 2020-10-27 Google Llc Systems and methods for guided user actions on a computing device
US10138717B1 (en) * 2014-01-07 2018-11-27 Novi Labs, LLC Predicting well performance with feature similarity
US11145417B2 (en) * 2014-02-04 2021-10-12 Optimata Ltd. Method and system for prediction of medical treatment effect
EP3117220B1 (en) 2014-03-12 2020-07-08 Icahn School of Medicine at Mount Sinai Method for identifying kidney allograft recipients at risk for chronic injury
CN104017806B (zh) * 2014-05-08 2017-11-10 复旦大学 microRNA及其在制备活动性结核病检测试剂中的应用
US11017881B2 (en) 2014-05-15 2021-05-25 Codondex Llc Systems, methods, and devices for analysis of genetic material
WO2015175602A1 (en) 2014-05-15 2015-11-19 Codondex Llc Systems, methods, and devices for analysis of genetic material
US10308985B2 (en) * 2014-06-26 2019-06-04 Icahn School Of Medicine At Mount Sinai Methods for diagnosing risk of renal allograft fibrosis and rejection
WO2015200887A2 (en) 2014-06-26 2015-12-30 Icahn School Of Medicine At Mount Sinai Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets
WO2016007549A1 (en) 2014-07-07 2016-01-14 Veramarx, Inc. Biomarker signatures for lyme disease and methods of use thereof
EP3180621B1 (en) 2014-08-14 2020-04-01 Memed Diagnostics Ltd. Computational analysis of biological data using manifold and a hyperplane
EP3189164B1 (en) * 2014-09-05 2021-11-10 American University Of Beirut Determination of risk for development of cardiovascular disease by measuring urinary levels of podocin and nephrin messenger rna
CN104278105A (zh) * 2014-11-07 2015-01-14 雷桅 一种检测冠心病的血清学生物标志物miR-19a及其用途
CN111624345A (zh) 2014-12-11 2020-09-04 米密德诊断学有限公司 用于诊断多种感染的标记组合及其使用方法
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
WO2016168336A1 (en) * 2015-04-14 2016-10-20 uBiome, Inc. Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions
DE102015216782B3 (de) * 2015-09-02 2017-01-26 Ikdt Institut Kardiale Diagnostik Und Therapie Gmbh Verwendung von im Blutserum oder Blutplasma zirkulierenden microRNAs zur Identifikation biopsiepflichtiger Patienten und als Marker zur Differentialdiagnose einzelner nicht-ischämischer Kardiomyopathien oder Speichererkrankungen des Herzens
CN106609301B (zh) * 2015-10-26 2019-10-25 北京大学人民医院 一种辅助诊断1型糖尿病的试剂盒
US11191490B2 (en) * 2015-12-02 2021-12-07 Siemens Healthcare Gmbh Personalized assessment of patients with acute coronary syndrome
EA201600076A1 (ru) * 2015-12-30 2017-07-31 Андрей Владимирович ТИТОВ Способ оценки состояния организма по образцам биологической жидкости, получаемой неинвазивно
WO2017119881A1 (en) * 2016-01-06 2017-07-13 Veramarx, Inc. Biomarker signatures for lyme disease differentiation and methods of use thereof
EP3196317A1 (en) 2016-01-21 2017-07-26 Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Predictive methods of atherosclerosis and stenosis
CN105486878B (zh) * 2016-01-22 2018-02-06 徐超 一种临床个体化组合用药的筛选系统及其方法
CN105445408B (zh) * 2016-01-25 2018-06-12 齐炼文 诊断区分冠状动脉粥样硬化和稳定型心绞痛的代谢标志物
CN107194138B (zh) * 2016-01-31 2023-05-16 北京万灵盘古科技有限公司 一种基于体检数据建模的空腹血糖预测方法
IL287757B (en) 2016-03-03 2022-07-01 Memed Diagnostics Ltd Analyzing rna for diagnosing infection type
CN105713972A (zh) * 2016-03-16 2016-06-29 上海中医药大学 miRNA在制备药物性心脏病生物标志物中的用途
CN109804245B (zh) 2016-07-10 2022-10-25 米密德诊断学有限公司 感染的早期诊断
EP4141448A1 (en) * 2016-07-10 2023-03-01 MeMed Diagnostics Ltd. Protein signatures for distinguishing between bacterial and viral infections
WO2018060998A1 (en) 2016-09-29 2018-04-05 Memed Diagnostics Ltd. Methods of prognosis and treatment
US11205103B2 (en) 2016-12-09 2021-12-21 The Research Foundation for the State University Semisupervised autoencoder for sentiment analysis
US20180166170A1 (en) * 2016-12-12 2018-06-14 Konstantinos Theofilatos Generalized computational framework and system for integrative prediction of biomarkers
AU2018205825A1 (en) * 2017-01-06 2019-08-15 Codondex Llc Systems, methods, and devices for analysis of genetic material
EP3574318B1 (en) * 2017-01-27 2020-12-09 Becton, Dickinson and Company Vertical flow assay device for detecting glucose concentration in a fluid sample
EP3647422B1 (en) * 2017-06-29 2024-07-24 Toray Industries, Inc. Kit, device, and method for lung cancer detection
TWI641963B (zh) * 2017-07-07 2018-11-21 長庚醫療財團法人林口長庚紀念醫院 Method for screening coronary heart disease by cardiovascular marker and mechanical learning algorithm
CN111279194A (zh) 2017-09-30 2020-06-12 阿尔佛雷德医疗集团 预后方法
CA3081752A1 (en) * 2017-11-02 2019-05-09 Prevencio, Inc. Diagnostic and prognostic methods for peripheral arterial diseases, aortic stenosis, and outcomes
CN113116918B (zh) * 2017-12-29 2022-06-14 中国科学院上海药物研究所 靶向PCSK9的microRNA在治疗LDLC相关代谢性疾病中的应用
CN108004316A (zh) * 2018-01-09 2018-05-08 青岛大学 用于预测急性心肌梗死风险的试剂盒
CN108376564A (zh) * 2018-02-06 2018-08-07 天津艾登科技有限公司 基于随机森林算法的疾病诊断并发症识别方法及系统
CN108070650B (zh) * 2018-02-09 2021-02-12 深圳承启生物科技有限公司 外泌体中microRNA在诊断缺血性脑卒中疾病的用途
US10915729B2 (en) * 2018-02-20 2021-02-09 The Regents Of The University Of Michigan Three-dimensional cell and tissue image analysis for cellular and sub-cellular morphological modeling and classification
CN108492272B (zh) * 2018-03-26 2021-01-19 西安交通大学 基于注意力模型及多任务神经网络的心血管易损斑块识别方法及系统
WO2019204267A1 (en) 2018-04-16 2019-10-24 Icahn School Of Medicine At Mount Sinai Method and kits for prediction of acute rejection and renal allograft loss using pre-transplant transcriptomic signatures in recipient blood
WO2019217714A1 (en) * 2018-05-09 2019-11-14 The General Hospital Corporation Determination and reduction of risk of sudden cardiac death
RU2677280C1 (ru) * 2018-05-17 2019-01-16 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ диагностики многососудистого атеросклеротического поражения коронарных артерий у больных ишемической болезнью сердца при абдоминальном ожирении
CN108728437A (zh) * 2018-05-25 2018-11-02 中国人民解放军陆军军医大学 促进骨骼肌损伤修复的寡核苷酸、药物及应用
US12292451B2 (en) * 2018-06-08 2025-05-06 Cleveland Clinic Foundation ApoA1 exchange rate assays in serum
CN108803994B (zh) * 2018-06-14 2022-10-14 四川和生视界医药技术开发有限公司 视网膜血管的管理方法及视网膜血管的管理装置
CN109009222A (zh) * 2018-06-19 2018-12-18 杨成伟 面向心脏病类型和严重程度的智能评估诊断方法及系统
CN108796070B (zh) * 2018-07-16 2022-09-30 辽宁中医药大学 miR-125a-3p在制备心血管疾病诊断试剂盒中的用途
CN108998514B (zh) * 2018-08-20 2022-02-01 青岛大学 miRNA-378及其抑制剂的应用和应用其的产品
CN109411015B (zh) * 2018-09-28 2020-12-22 深圳裕策生物科技有限公司 基于循环肿瘤dna的肿瘤突变负荷检测装置及存储介质
US11928985B2 (en) * 2018-10-30 2024-03-12 International Business Machines Corporation Content pre-personalization using biometric data
KR102165841B1 (ko) * 2018-11-05 2020-10-14 순천향대학교 산학협력단 당뇨병 진단을 위한 마이크로RNA let-7b 또는 마이크로RNA-664a 바이오마커 및 이의 용도
EP3886696A4 (en) * 2018-11-29 2022-08-24 SomaLogic Operating Co., Inc. Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
CN110229893A (zh) * 2019-02-04 2019-09-13 金华市中心医院 用于诊断颈动脉粥样硬化斑块的miRNAs标志物及其应用
CN110082536B (zh) * 2019-04-17 2022-06-10 广州医科大学附属肿瘤医院 一种乳腺癌细胞标志物细胞因子群及其应用
US11030743B2 (en) * 2019-05-16 2021-06-08 Tencent America LLC System and method for coronary calcium deposits detection and labeling
WO2020260554A1 (en) * 2019-06-26 2020-12-30 Westfälische Wilhelms-Universität Münster Method for establishing an individual physical activity program for a subject for reducing an individual risk of the subject for developing a cardiovascular disease
CN111154870B (zh) * 2019-08-05 2023-06-23 江苏省肿瘤医院 一种鼻咽癌转移诊断和/或预后评估的生物标记
CN111275125A (zh) * 2020-02-10 2020-06-12 东华大学 一种面向低秩图像特征分析的类别标签恢复方法
US11058710B1 (en) 2020-02-14 2021-07-13 Dasman Diabetes Institute MicroRNA ANGPTL3 inhibitor
CN111718991A (zh) * 2020-07-03 2020-09-29 西安交通大学医学院第一附属医院 血浆miRNA分子标志物在诊断代谢综合征中的应用
CN114058696B (zh) * 2020-07-29 2023-08-18 四川大学华西医院 miR-519e-5p作为甲状腺乳头状癌远处转移检测或治疗靶点中的用途
CN114113624B (zh) * 2020-08-28 2024-08-16 香港城市大学深圳研究院 利用免疫球蛋白关联蛋白质组开发疾病标志物的方法及装置
EP3971909A1 (en) * 2020-09-21 2022-03-23 Thorsten Kaiser Method for predicting markers which are characteristic for at least one medical sample and/or for a patient
CN112280845A (zh) * 2020-09-22 2021-01-29 山东大学第二医院 miR-328-3p在制备脑梗死及脑缺血再灌注预后预测试剂中的应用
CN114520054A (zh) * 2020-11-18 2022-05-20 英业达科技有限公司 心衰竭预测组件及心衰竭预测方法
CN112530595A (zh) * 2020-12-21 2021-03-19 无锡市第二人民医院 一种基于多分支链式神经网络的心血管疾病分类方法和装置
CN112680509A (zh) * 2021-01-20 2021-04-20 河南省中医院（河南中医药大学第二附属医院） 一种评估冠心病预后分子标志物miR-302e及其逆转录引物、扩增引物和应用
CN112904020A (zh) * 2021-01-25 2021-06-04 上海市第六人民医院 Fam172a在筛查和治疗糖尿病大血管病变中的应用
CN112509700A (zh) * 2021-02-05 2021-03-16 中国医学科学院阜外医院 稳定型冠心病的风险预测方法及装置
CN112941167A (zh) * 2021-03-16 2021-06-11 宁夏医科大学 一种心血管疾病诊断用miRNA标志物及其应用
EP4326894A4 (en) * 2021-04-24 2025-06-04 University of Notre Dame du Lac Method and device for detection of myocardial infarction and reperfusion injury
CN113293207B (zh) * 2021-06-22 2022-09-02 上海市东方医院（同济大学附属东方医院） 外周血miRNA在制备作为心衰诊断或者预后的生物标志物中的用途
JP2024535756A (ja) * 2021-09-07 2024-10-02 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレイテッド バイオマーカー組成物およびその使用方法
CN113943792A (zh) * 2021-11-02 2022-01-18 石河子大学 检测miRNA表达量的试剂在制备诊断或预后哈萨克族高血压的试剂或试剂盒中的应用
CN115901901A (zh) * 2022-01-15 2023-04-04 山东师范大学 TiO2-MoO3纳米阵列及基于其的miR-145-3p早检传感芯片及其应用
CN114388121B (zh) * 2022-03-25 2022-06-03 北京盛坤康如医疗器械有限责任公司 心脏标志物poct系统及医疗器材
EP4533484A1 (en) * 2022-06-03 2025-04-09 Foundation Medicine, Inc. Methods and systems for classification of disease entities via mixture modeling
CN114990229B (zh) * 2022-06-20 2023-01-03 广东医科大学附属医院 一种嗜碱性粒细胞活化相关的生物标志物及其应用
CN116334206A (zh) * 2022-11-09 2023-06-27 上海长征医院 miR-541在制备肝纤维化/肝硬化无创诊断及预后评估试剂盒中的应用
KR20250031367A (ko) * 2023-08-28 2025-03-07 고려대학교 산학협력단 동맥경화증 진단용 엑소좀 유래 바이오 마커
WO2025135469A1 (ko) * 2023-12-22 2025-06-26 서울대학교병원 대사질환 예측 또는 진단을 위한 마이크로 rna 바이오마커 및 이의 용도
CN117737262A (zh) * 2024-02-21 2024-03-22 山东第一医科大学(山东省医学科学院) 一种miRNA标志物在制备鉴别体液斑产品中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009501318A (ja) * 2005-06-24 2009-01-15 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ アテローム動脈硬化性心血管疾患の診断およびモニタリングのための方法ならびに組成物
WO2009012468A2 (en) * 2007-07-18 2009-01-22 The Regents Of The University Colorado Differential expression of micrornas in nonfailing versus failing human hearts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6059724A (en) * 1997-02-14 2000-05-09 Biosignal, Inc. System for predicting future health
US7888497B2 (en) * 2003-08-13 2011-02-15 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory oligonucleotides and uses thereof
US7306562B1 (en) * 2004-04-23 2007-12-11 Medical Software, Llc Medical risk assessment method and program product
US7635563B2 (en) * 2004-06-30 2009-12-22 Massachusetts Institute Of Technology High throughput methods relating to microRNA expression analysis
WO2008043521A2 (de) * 2006-10-09 2008-04-17 Julius-Maximilians-Universität Würzburg Microrna (mirna) zur diagnose und therapie von herzerkrankungen
SG177948A1 (en) * 2006-10-19 2012-02-28 Entelos Inc Method and apparatus for modeling atherosclerosis
WO2008080126A2 (en) * 2006-12-22 2008-07-03 Aviir, Inc. Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease
US8768718B2 (en) * 2006-12-27 2014-07-01 Cardiac Pacemakers, Inc. Between-patient comparisons for risk stratification of future heart failure decompensation
US20090156906A1 (en) * 2007-06-25 2009-06-18 Liebman Michael N Patient-centric data model for research and clinical applications
US20110160285A1 (en) * 2008-03-13 2011-06-30 The Regents Of The University Of Colorado Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy
SG177938A1 (en) * 2008-03-26 2012-02-28 Theranos Inc Methods and systems for assessing clinical outcomes
US8224665B2 (en) * 2008-06-26 2012-07-17 Archimedes, Inc. Estimating healthcare outcomes for individuals

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009501318A (ja) * 2005-06-24 2009-01-15 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ アテローム動脈硬化性心血管疾患の診断およびモニタリングのための方法ならびに組成物
WO2009012468A2 (en) * 2007-07-18 2009-01-22 The Regents Of The University Colorado Differential expression of micrornas in nonfailing versus failing human hearts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JPN6015004064; Ｐｈｙｓｉｏｌ．　Ｇｅｎｏｍｉｃｓ ｖｏｌ．３１，　ｎｏ．３, 2007, ｐｐ．３６７-３７３ *

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013528055A (ja) * 2010-06-07 2013-07-08 キングス カレッジ ロンドン 検出方法
JP2019207249A (ja) * 2014-09-26 2019-12-05 ソマロジック, インコーポレイテッドSomaLogic, Inc. 心血管系のリスクイベントの予測及びその使用
JP2017530356A (ja) * 2014-09-26 2017-10-12 ソマロジック, インコーポレイテッドSomaLogic, Inc. 心血管系のリスクイベントの予測及びその使用
JP2016114606A (ja) * 2014-12-15 2016-06-23 学校法人 久留米大学 腎性貧血のバイオマーカーとしての赤血球ａｄｍａの使用
KR101903526B1 (ko) * 2015-08-19 2018-10-05 한국전자통신연구원 바이오 물질의 농도를 기반으로 하는 질환 예측 장치 및 그것의 질환 예측 방법
JP2019511242A (ja) * 2016-01-22 2019-04-25 ユニヴェルシテ ドュ モンペリエＵｎｉｖｅｒｓｉｔｅ Ｄｅ Ｍｏｎｔｐｅｌｌｉｅｒ 生物学的サンプルを分類する方法
JP2021128177A (ja) * 2016-02-01 2021-09-02 プレベンシオ， インコーポレイテッド 心臓血管疾患及び事象のための診断及び予後方法
JP2019507354A (ja) * 2016-02-01 2019-03-14 プレベンシオ， インコーポレイテッド 心臓血管疾患及び事象のための診断及び予後方法
JP7134870B2 (ja) 2016-02-01 2022-09-12 プレベンシオ， インコーポレイテッド 心臓血管疾患及び事象のための診断及び予後方法
JP7403498B2 (ja) 2016-02-01 2023-12-22 プレベンシオ， インコーポレイテッド 心臓血管疾患及び事象のための診断及び予後方法
US12146888B2 (en) 2016-02-01 2024-11-19 Prevencio, Inc. Diagnostic methods for cardiovascular diseases
JP2019513993A (ja) * 2016-03-31 2019-05-30 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ 急性冠症候群のリスクを推定するための決定木ベースのシステム及び方法
JP7228384B2 (ja) 2016-03-31 2023-02-24 アボット・ラボラトリーズ 急性冠症候群のリスクを推定するための決定木ベースのシステム及び方法
JP2023062032A (ja) * 2016-03-31 2023-05-02 アボット・ラボラトリーズ 急性冠症候群のリスクを推定するための決定木ベースのシステム及び方法
JP7762680B2 (ja) 2016-03-31 2025-10-30 アボット・ラボラトリーズ 急性冠症候群のリスクを推定するための決定木ベースのシステム及び方法
JP2022505676A (ja) * 2018-10-23 2022-01-14 ブラックソーン セラピューティクス インコーポレイテッド 患者のスクリーニング、診断、及び層別化のためのシステム及び方法
JP2022550598A (ja) * 2019-10-02 2022-12-02 エンドポイント ヘルス インコーポレイテッド 宿主反応調節不全の治療を誘導するためのバイオマーカーパネル
JP7745542B2 (ja) 2019-10-02 2025-09-29 エンドポイント ヘルス インコーポレイテッド 宿主反応調節不全の治療を誘導するためのバイオマーカーパネル
JP2023502197A (ja) * 2019-11-04 2023-01-23 オックスフォード ユニバーシティ イノベーション リミティド 除草剤および植物成長調節剤の特定および特性決定

Also Published As

Publication number Publication date
US20150376704A1 (en) 2015-12-31
AU2010328019A2 (en) 2012-06-28
AU2010328019A1 (en) 2012-06-28
CN102762743A (zh) 2012-10-31
CA2783536A1 (en) 2011-06-16
WO2011072177A2 (en) 2011-06-16
US20110144914A1 (en) 2011-06-16
EP2510116A2 (en) 2012-10-17
WO2011072177A3 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
JP2013513387A (ja) 循環器疾患の診断と分類のためのバイオマーカーアッセイ
CA3133639A1 (en) Systems and methods for deriving and optimizing classifiers from multiple datasets
US20080300797A1 (en) Two biomarkers for diagnosis and monitoring of atherosclerotic cardiovascular disease
US9238841B2 (en) Multi-biomarker-based outcome risk stratification model for pediatric septic shock
JP2019207249A (ja) 心血管系のリスクイベントの予測及びその使用
US20090062144A1 (en) Gene signature for prognosis and diagnosis of lung cancer
JP2017506510A (ja) 敗血症の発症を予測するための装置、キット及び方法
JP2009501318A (ja) アテローム動脈硬化性心血管疾患の診断およびモニタリングのための方法ならびに組成物
US20240194294A1 (en) Artificial-intelligence-based method for detecting tumor-derived mutation of cell-free dna, and method for early diagnosis of cancer, using same
JP2021092573A (ja) 乾癬性関節炎の疾患活動性を評価するためのバイオマーカーおよび方法
AU2021236680A1 (en) Systems and methods of detecting a risk of Alzheimer's disease using a circulating-free mRNA profiling assay
JP2024527461A (ja) 組織特異的調節領域の無細胞ｄｎａ分布を用いた人工知能基盤の癌早期診断方法
EP4428864A1 (en) Method for diagnosing cancer by using sequence frequency and size at each position of cell-free nucleic acid fragment
JP5307996B2 (ja) 判別因子セットを特定する方法、システム及びコンピュータソフトウェアプログラム
CN121002198A (zh) 用于鉴别一种或多种预测性生物标志物的人工智能
US20250084481A1 (en) Assessment and diagnosis myxomatous mitral valve disease using a microrna assay
US20250305048A1 (en) Assessment and differential diagnosis of cardiovascular disease in companion animals using a microrna assay
US20250046451A1 (en) Generative Adversarial Network for Urine Biomarkers
EP4232825B1 (en) Cardiovascular event risk prediction
CN108603870A (zh) 冠状动脉疾病的标记物及其用途
WO2025184472A1 (en) Plasma cell-free rna signatures of inflammatory syndromes in children
WO2025056769A1 (en) Method for assessing systemic inflammation

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150430

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150602

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150630

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20151020